Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

59.45 +0.02 (+0.03%)

Streaming Delayed Price Updated: 4:00 PM EST, Jan 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,143,440
Open	59.43
Bid (Size)	58.00 (100)
Ask (Size)	61.50 (100)
Prev. Close	59.43
Today's Range	58.89 - 59.82
52wk Range	50.76 - 73.51
Shares Outstanding	183,352,255
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BioMarin’s $4.8 Billion Amicus Acquisition: A Strategic Pivot to Rare Disease Dominance

January 02, 2026

In a move that has sent shockwaves through the biotechnology sector, BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced on December 19, 2025, that it has entered into a definitive agreement to...

Via MarketMinute

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Emerges as a 'Decent Value' Candidate ↗

January 02, 2026

Via Chartmill

Performance

YTD	N/A	N/A
1 Month	+9.5%	+9.5%
3 Month	+7.3%	+7.3%
6 Month	+3.6%	+3.6%
1 Year	-10.6%	-10.6%

More News

Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal

December 29, 2025

Via MarketMinute

Amicus Stock Surges To Near 2-Year Highs On BioMarin's $4.8B Buyout Deal ↗

December 19, 2025

Via Stocktwits

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Clearwater Analytics Holdings, Inc. (NYSE - CWAN), Katapult Holdings, Inc. (Nasdaq - KPLT), Janus Henderson Group plc (NYSE - JHG), Amicus Therapeutics, Inc. (Nasdaq

December 23, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know

December 23, 2025

Via StockStory

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

December 19, 2025

Via StockStory

Which stocks are gapping on Friday? ↗

December 19, 2025

Via Chartmill

1 Oversold Stock Primed to Rebound and 2 That Underwhelm

December 15, 2025

Via StockStory

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Presents a Compelling Value Investment Case ↗

December 08, 2025

Via Chartmill

Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms ↗

December 03, 2025

Via The Motley Fool

PTC Therapeutics Swings to a Profit on $211 Million in Revenue — Is This Why a Major Fund Just Invested $32 Million? ↗

December 03, 2025

Via The Motley Fool

Dyne Therapeutics Stock Down 30% in a Year — So Why Did One Investor Add Nearly 1 Million Shares? ↗

December 03, 2025

Via The Motley Fool

Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results

December 03, 2025

Via MarketMinute

2 Reasons to Like BMRN and 1 to Stay Skeptical

November 24, 2025

Via StockStory

Q3 Earnings Outperformers: BioMarin Pharmaceutical (NASDAQ:BMRN) And The Rest Of The Therapeutics Stocks

November 23, 2025

Via StockStory

AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

November 21, 2025

Via StockStory

BioMarin Pharmaceutical (BMRN): Buy, Sell, or Hold Post Q3 Earnings?

November 20, 2025

Via StockStory

Cidara Therapeutics Is Up Over 100%. Here's What Investors Need to Know. ↗

November 20, 2025

Via The Motley Fool

The Tech Tsunami: How Breakthroughs in AI, Quantum, and Green Energy Are Reshaping the Stock Market

November 14, 2025

Via MarketMinute

1 Safe-and-Steady Stock on Our Watchlist and 2 We Question

November 12, 2025

Via StockStory

Viatris, Oscar Health, BioMarin Pharmaceutical, QuidelOrtho, and Bausch + Lomb Stocks Trade Up, What You Need To Know

November 11, 2025

Via StockStory

3 Cash-Producing Stocks with Promising Prospects

November 09, 2025

Via StockStory

This Zimmer Biomet Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

November 06, 2025

Via Benzinga

BIOMARIN PHARMACEUTICAL INC (NASDAQ:BMRN) Presents a Compelling Value Investment Case ↗

November 05, 2025

Via Chartmill

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?

Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.

What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?

BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?

The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market

What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?

The current price of BioMarin Pharmaceutical Inc. - Common Stock is 59.45

When was BioMarin Pharmaceutical Inc. - Common Stock last traded?

The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 01/02/26 04:00 PM ET

What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?

The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 10.90B

How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?

BioMarin Pharmaceutical Inc. - Common Stock has 11B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.